Akash Puranik News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bangalore (Karnataka) [India], November 24 (ANI/PRNewswire): Symbio Generrics India Private Limited (Symbio), a specialized Active Pharmaceutical Ingredients (API) & Intermediates manufacturing and marketing organization, announced today that it has completed an equity capital raise from Ascent Capital, a leading growth-capital focused private equity fund. Symbio was founded by pharmaceutical professionals, Salim Shaikh and Abhijit Kale. They were soon joined by the third promoter, Akash Puranik; all of whom possess decades of experience in the global pharmaceutical industry. Symbio's journey from a sales and marketing organization to a full-fledged vertically integrated manufacturer of specialized APIs has been exemplary. Through a well-developed customer ecosystem, the highly experienced & skilled team at Symbio has established a global footprint for its APIs. Ascent Capital's sizeable investment in Symbio will further accelerate the company's expansion plans and

Andhra pradeshRaja kumarSymbio generricsAkash puranikSameena chatrapathySalim shaikhAbhijit kaleRd centreEquity fund managerSymbio generrics india private limitedFinancial servicesActive pharmaceutical ingredientsNascent capitalExecutive chairmanSenior partnerGenerrics india private limited